Japanese pharmaceutical contract development and manufacturing organization (CDMO) Peptistar has integrated Asahi Kasei's ...

In the global pharmaceutical manufacturing landscape, HK Neopharm Limited has been increasingly recognized by industry observers as a noteworthy participant in the active pharmaceutical ingredient ...

QINGDAO, CHINA, January 19, 2026 /EINPresswire.com/ — As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened ...

DUBLIN, May 10, 2021 /PRNewswire/ -- The "Global Active Pharmaceutical Ingredient Market (2020-2025) by Type, Molecule, Product Type, Formulation Type, Manufacturing Type, Synthesis Type, Drug Type, ...

Zhejiang Hengkang Pharmaceutical Co., Ltd. continues to strengthen its position as a leading manufacturer within the global active pharmaceutical ingredient industry, attracting growing attention for ...

Industry leaders say the inclusion of 77 raw materials under new or expanded duty concessions will help reduce procurement ...

India's Garonit Pharmaceutical plans to build a $46.1 million production plant in New York to produce chlorhexidine gluconate. (artplus/Getty Images) Garonit Pharmaceutical, an India-based API maker, ...

India hosts more active pharmaceutical ingredient (API) manufacturing sites that are compliant with the U.S. Food and Drug Administration than any country outside the U.S., and it produces more ...

LONGMONT, Colo.--(BUSINESS WIRE)--Avista Pharma Solutions, Inc. (“Avista Pharma”) has completed facility upgrades that effectively double the company’s API manufacturing capacity at its Longmont, ...

Voyageur Pharmaceuticals Ltd. (TSX-V: VM) (OTC Pink: VYYRF) ("Voyageur" or the "Company"), a Canadian developer of ...

US opens Section 301 probe into Germany's drug pricing, threatening tariffs that could disrupt API supply chains and reshape ...